sacituzumab govitecan
gilead sciences
['bcsm', 'biomarker', 'tropics02']
 discusses tropics02
sacituzumab versus physician choice chemotherapy in heavily pretreated hr+/her2- bc. pfs 5.5 v 4.0 m (hr 0.66)
os immature a positive study. biomarker needed. trop2 level analysis will be interesting. #bcsm #asco2022 
Breast Medical Oncologist @dukecancer. Clinical investigator. Mom of ???. Tweet=own opinion.